» Authors » Alireza Mosavi-Jarrahi

Alireza Mosavi-Jarrahi

Explore the profile of Alireza Mosavi-Jarrahi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 368
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Samareh Salavatipour M, Tavakoli S, Halimi A, Tavoosi S, Baghsheikhi A, Talebi-Taheri A, et al.
Front Pharmacol . 2024 Dec; 15:1356634. PMID: 39664521
Background: Ubiquitin-specific peptidases (USPs), also known as deubiquitinating enzymes (DUBs), play a crucial role in maintaining cellular homeostasis by selectively removing ubiquitin molecules from targeted proteins. This process affects protein...
2.
Mhaidat I, Taherian M, Hashemi Nazari S, Mosavi-Jarrahi A, Yeganeh H, Al-Yateem N, et al.
BMJ Open . 2023 May; 13(5):e067115. PMID: 37173114
Introduction: Approximately 0.5 million fatalities per year are attributed to substance use disorder (SUD). SUD is refractory to therapy and has a high relapse rate. Cognitive deficits are also common...
3.
Khodadost M, Fattahi A, Nejad N, Shokri A, Fattahi H, Sarvi F, et al.
Iran J Public Health . 2022 Jul; 51(3):659-668. PMID: 35865054
Background: Cancers seldom happen in childhood age and awareness of accurate cancer incidence is essential in order to preventive programs. This study aimed to estimate the childhood cancer incidence in...
4.
Laali A, Tabibzadeh A, Esghaei M, Yousefi P, Soltani S, Ajdarkosh H, et al.
Adv Biomed Res . 2021 Apr; 9:74. PMID: 33912490
Background: Since the start of coronavirus epidemic in Wuhan, China, in early December 2019, many literatures addressed its epidemiology, virology, and clinical presentation. In this review, we systematically reviewed the...
5.
Tabibzadeh A, Zamani F, Laali A, Esghaei M, Safarnezhad Tameshkel F, Keyvani H, et al.
Infect Genet Evol . 2020 Jun; 84:104387. PMID: 32485332
Background: The aim of the current study was to investigate and track the SARS-CoV-2 in Iranian Coronavirus Disease 2019 (COVID-19) patients using molecular and phylogenetic methods. Methods: We enrolled seven...
6.
Karimi-Zarchi M, Moghimi M, Abbasi H, Hadadan A, Salimi E, Morovati-Sharifabad M, et al.
Asian Pac J Cancer Prev . 2019 Sep; 20(9):2569-2577. PMID: 31554347
Background: Previous studies have evaluated the impact of MTHFR 677C>T polymorphism on susceptibility to ovarian and cervical cancers in women, but the conclusions are still controversial. To get a more...
7.
Mansori K, Solaymani-Dodaran M, Mosavi-Jarrahi A, Motlagh A, Salehi M, Delavari A, et al.
Med J Islam Repub Iran . 2019 Aug; 33:23. PMID: 31380313
This study aimed to determine effective factors on geographic distribution of the Incidence of Colorectal Cancer (CRC) in Tehran, Iran using Geographically Weighted Poisson Regression Model. This ecological study was...
8.
Keramatinia A, Mohseny M, Akbari M, Mosavi-Jarrahi A, Monfared E, Amanpour F, et al.
J Res Med Sci . 2019 Jan; 23:101. PMID: 30595709
Background: Cancer is the second most common cause of morbidity and mortality in children. This study aimed to epidemiologically and demographically assess common cancers in children in Iran. Materials And...
9.
Sasanpour P, Sandoughdaran S, Mosavi-Jarrahi A, Malekzadeh M
Asian Pac J Cancer Prev . 2018 Sep; 19(9):2423-2427. PMID: 30255695
Background: Achievement of pathologic complete response (pCR) in breast cancer patients receiving neoadjuvant chemotherapy (NAC) is associated with both overall survival and disease-free survival. The aim of present study was...
10.
Mansori K, Mosavi-Jarrahi A, Motlagh A, Solaymani-Dodaran M, Salehi M, Delavari A, et al.
Asian Pac J Cancer Prev . 2018 Apr; 19(4):1099-1104. PMID: 29699370
Objectives: Colorectal cancer (CRC) may now be the second most common cancer in the world. The aim of this study was to determine whether clusters of high and low risk...